Published date: 
Thursday, 18 May, 2023

The World Health Organiazation recommends use of the RTS,S/AS01 malaria vaccine for young children living in areas of moderate to high Plasmodium falciparum malaria transmission and suggests countries consider seasonal vaccination in areas with highly seasonal malaria. Seasonal vaccination is uncommon and may require adaptations with potential cost consequences.

This study prospectively estimates cost of seasonal malaria vaccine delivery in Mali and Burkina Faso. Three scenarios for seasonal vaccine delivery are costed (1) mass campaign only, (2) routine Expanded Programme on Immunisation (EPI) and (3) mixed delivery (mass campaign and routine EPI)), from the government’s perspective. Resource use data are informed by previous new vaccine introductions, supplemented with primary data from a sample of health facilities and administrative units.

Vaccine delivery using the mass campaign approach is most costly followed by mixed delivery and routine EPI delivery approaches, in both countries. Our cost estimates provide useful insights for decisions regarding delivery approaches, as countries plan the malaria vaccine rollout.

Diawara H, Bocoum FY, Dicko A, et al. Cost of introducing and delivering malaria vaccine (RTS,S/AS01) in areas of seasonal malaria transmission, Mali and Burkina Faso. BMJ Global Health 2023;8:e011316.